COO broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 38 similar instances where the stock broke above the upper band. In 25 of the 38 cases the stock fell afterwards. This puts the odds of success at 66%.
The 10-day RSI Indicator for COO moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 10 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 36%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 63 cases where COO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on COO as a result. In 45 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
COO moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for COO crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 152 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 115 of 222 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.424) is normal, around the industry mean (4.964). P/E Ratio (21.283) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ICUI's Aroon Indicator triggered a bullish signal on November 09, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator showed a similar pattern. In 154 of the 204 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 75%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ICUI as a result. In 62 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on November 04, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.
ICUI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ICUI crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +6.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 188 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 58 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
ICUI broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.000) is normal, around the industry mean (4.964). ICUI has a moderately high P/E Ratio (143.425) as compared to the industry average of (40.591). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
COO | ICUI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 89 | |
PRICE GROWTH RATING 1..100 | 49 | 40 | |
P/E GROWTH RATING 1..100 | 85 | 97 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
COO's Valuation (59) in the Medical Specialties industry is in the same range as ICUI (87). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's SMR Rating (80) in the Medical Specialties industry is in the same range as ICUI (89). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
ICUI's Price Growth Rating (40) in the Medical Specialties industry is in the same range as COO (49). This means that ICUI’s stock grew similarly to COO’s over the last 12 months.
COO's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as ICUI (97). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
| COO | ICUI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 36% | N/A |
| Stochastic ODDS (%) | 1 day ago 54% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 51% | 1 day ago 67% |
| MACD ODDS (%) | N/A | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 56% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 73% |
| Advances ODDS (%) | 22 days ago 56% | 1 day ago 68% |
| Declines ODDS (%) | 5 days ago 60% | 8 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 66% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 52% | 1 day ago 75% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COO’s FA Score shows that 0 FA rating(s) are green while ICUI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COO’s TA Score shows that 5 TA indicator(s) are bullish while ICUI’s TA Score has 6 bullish TA indicator(s).
COO (@Pharmaceuticals: Other) experienced а +4.29% price change this week, while ICUI (@Pharmaceuticals: Other) price change was +10.14% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.53%. For the same industry, the average monthly price growth was +4.73%, and the average quarterly price growth was +18.71%.
COO is expected to report earnings on Dec 03, 2026.
ICUI is expected to report earnings on Mar 03, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.
| Ticker / NAME | Correlation To COO | 1D Price Change % | ||
|---|---|---|---|---|
| COO | 100% | +2.52% | ||
| A - COO | 50% Loosely correlated | +3.10% | ||
| BDX - COO | 50% Loosely correlated | +1.59% | ||
| ICUI - COO | 48% Loosely correlated | +3.92% | ||
| SOLV - COO | 47% Loosely correlated | +0.06% | ||
| DHR - COO | 46% Loosely correlated | +2.12% | ||
More | ||||
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | +3.92% | ||
| CLPT - ICUI | 57% Loosely correlated | +6.63% | ||
| ALGN - ICUI | 53% Loosely correlated | +4.98% | ||
| MMSI - ICUI | 52% Loosely correlated | +1.36% | ||
| A - ICUI | 50% Loosely correlated | +3.10% | ||
| COO - ICUI | 49% Loosely correlated | +2.52% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BCSM | 25.13 | 0.84 | +3.46% |
| Baron SMID Cap ETF (BCSM) | |||
| BINT | 31.54 | 0.85 | +2.77% |
| Bluemonte Global Equity ETF (BINT) | |||
| ITAN | 45.12 | 0.90 | +2.04% |
| Sparkline Intangible Value ETF (ITAN) | |||
| NAD | 10.98 | 0.07 | +0.64% |
| Nuveen Quality Municipal Income Fund | |||
| CTEX | 30.46 | N/A | N/A |
| ProShares S&P Kensho Cleantech ETF (CTEX) | |||